This study aims to define the contribution of cancer and chemotherapy to muscle and systemic alterations that drive the onset of cachexia in rectal cancer patients and validate in human cancer cachexia (CC) the alterations in mitochondrial function and neuromuscular junction (NMJ) observed in the experimental models, thus providing the rationale for potential anti-cachexia strategies based on exercise and or exercise mimetics.
This is a multicenter observational prospective cohort study in rectal cancer patients after neoadjuvant therapy (ycTNM) stage II, III, and IV (AJCC 8th edit), clinically stratified in the pre-cachectic or cachectic stage according to Fearon K et al. definition. That will be subject to curative or palliative surgery through any surgical approach. And a control subgroup of patients who will undergo any abdominal surgery type through any approach type for no neoplastic or inflammatory disease. The study will take place in four Italian centers of colorectal surgery. Will be run a preoperatory physical performance, and will be recorded the physical activity by wearing a SmartWatch. The quantity of muscle will be estimated by the cross-sectional area (CSA) or the skeletal muscle area (SMA) from the magnetic resonance imaging (MRI) or computed tomography CT, respectively, and the Skeletal muscle index (SMI). The muscular quality will be studied by the mean skeletal muscle radiation attenuation (SMRA) and MRI proton density fat fraction (PDFF). All these parameters will be calculated by a radiologist from the preoperative MRI or CT imaging study. The study includes the analysis of preoperatory inflammatory and nutritional biomarkers. And a muscular biopsy harvested by the surgeon from the rectum or oblique abdominal during rectal resection-palliative surgery. The sample will undergo morphological and structural studies using histology, immunohistochemical, immunofluorescence, biochemical, and molecular analyses.
Study Type
OBSERVATIONAL
Enrollment
144
no intervention
Ospedale San Luigi Gonzaga
Orbassano, Turin, Italy
Physical function
Determinate by the short physical performance battery (SPPB) Score, a series of tests used to evaluate lower extremity function and mobility in older people. Scores are assigned according to performance, with an overall maximum score of 12. A cut off score \< 10 indicates mobility disability and cut point: ≤ 8 points for diagnosing of severe sarcopenia
Time frame: Preoperative.
Physical activity-Subjective Measurement
Determinate by the physical activity scale for the elderly (PASE) Score, the overall score ranging from 0 to 793, higher scores indicated greater physical activity
Time frame: Preoperative
Physical activity-Objective Measurement (step count)
Determinate by the average daily step count (total number of steps/14 days) recorded by wearing a Smart Watch for two weeks on consecutive days.
Time frame: Preoperative.
Physical activity-Objective Measurement (sleep)
Determinate by the average of daily sleep duration(total minutes of sleep/ 14 days) recorded by wearing a Smart Watch for two weeks on consecutive days.
Time frame: Preoperative.
Physical activity-Objective Measurement (sedentary time)
Determinate by the average daily sedentary time (total minutes of inactivity/14 days) recorded by wearing a Smart Watch for two weeks on consecutive days.
Time frame: Preoperative.
Physical activity-Objective Measurement (active time)
Determinate by the average daily active time (total duration of activity in minutes/14 days) recorded by wearing a Smart Watch for two weeks on consecutive days.
Time frame: Preoperative.
Muscular quantity
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Determinate by the Skeletal muscle index (SMI) = skeletal muscle area or cross-sectional area at L4-L5 (cm2)/height2(m2) from the preoperative magnetic resonance imaging.
Time frame: Preoperative.
Muscular quality (muscle fat content) by magnetic resonance imaging
Determinate by the proton density fat fraction (PDFF) of paraspinal muscles at L4-L5
Time frame: Preoperative.
Nutritional status - Albumin
Blood levels of albumin (g/dL).
Time frame: Preoperative.
Nutritional status - Prealbumin
Blood levels of prealbumin(mg/dL).
Time frame: Preoperative.
Nutritional status - transferrin
Blood levels of transferrin(mg/dL).
Time frame: Preoperative.
General health marker- hemoglobin
Blood levels of Hemoglobin (g/L).
Time frame: Preoperative.
Inflammatory status-White blood cells count
White blood cells count (10\^/L).
Time frame: Preoperative.
Inflammatory status - C-reactive protein
Blood levels of C-reactive protein (mg/dL).
Time frame: Preoperative.
Muscle wasting- creatine kinase
Blood levels of creatine kinase (U/L).
Time frame: Preoperative.
Morphometric analysis of skeletal muscle
Description of the dimension and type of muscular fibers from an abdominal wall muscle biopsy harvested intraoperatively.
Time frame: within 30 postoperative days.
Molecular analysis of skeletal muscle
Characterization of molecular signatures associated with Neo-adjuvant Chemotherapy and rectal cancer by comparing molecular profiles of a muscular biopsies harvested intraoperatively.
Time frame: within 60 postoperative days.
Muscle protein metabolism
Muscle-specific ubiquitin-ligases expression, mitophagy cargo shuttle, fusion-fission machinery, and mitochondrial biogenesis will be assayed from a muscular biopsy harvested intraoperatively.
Time frame: within 60 postoperative days.
Overall survival
to describe the percentage of participants who are alive three years after surgery
Time frame: 3 years after surgery.